Correlation Between Keros Therapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Keros Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for Keros Therapeutics and Corvus Pharmaceuticals
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Keros and Corvus is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Corvus Pharmaceuticals
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 10.81 times less return on investment than Corvus Pharmaceuticals. But when comparing it to its historical volatility, Keros Therapeutics is 1.78 times less risky than Corvus Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 202.00 in Corvus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 692.00 from holding Corvus Pharmaceuticals or generate 342.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Keros Therapeutics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Keros Therapeutics |
| Corvus Pharmaceuticals |
Keros Therapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite Keros Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Keros Therapeutics vs. ZyVersa Therapeutics | Keros Therapeutics vs. Sonnet Biotherapeutics Holdings | Keros Therapeutics vs. Zura Bio Limited | Keros Therapeutics vs. Phio Pharmaceuticals Corp |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |